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Abstract
Study design Retrospective secondary analysis with a quantitative, matched-pairs design. Patients isolated due to methicillin-
Resistant Staphylococcus aureus (MRSA) were matched with controls without MRSA infection admitted to a multi-bedded
ward, based on: gender, injury level, injury severity (AIS grade), age at the time of injury and year of admission.
Objectives Determine the implications of MRSA-related infection isolation on spinal cord injury patients’ anxiety,
depression, appraisals of disability, perceived manageability and pain intensity. Hypotheses predicted patients who were
isolated due to MRSA during inpatient stay would demonstrate poorer psychological health outcomes at discharge in
comparison with non-isolated matched controls.
Setting National Spinal Injuries Centre, England, UK.
Methods Secondary analyses were conducted on pre-existing data based on patients’ first admission for primary rehabili-
tation. Psychometric scales were used to measure outcome variables. Assessments were repeated at the time of admission
and discharge.
Results Nonparametric longitudinal analyses using the nparLD package in R were conducted. Relative treatment effects
demonstrated that there were no significant differences between groups across all outcome measures. There was a significant
effect of time (admission vs discharge) on perceived manageability and pain intensity, indicating improved outcomes at
discharge. There was no difference in the overall length of stay between the isolated and non-isolated groups.
Conclusions Isolation experienced by rehabilitation inpatients with spinal cord injury with MRSA had no effect on a series
of psychological outcomes. Engaging with rehabilitation had a positive impact in reducing pain unpleasantness and
increasing perceived manageability of spinal cord injury, irrespective of infection isolation.
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is an
antibiotic-resistant bacterium that is difficult to treat and
easily transmitted with specific stigmatisation [1–4].
Patients with a spinal cord injury (SCI) are particularly at
risk for contracting MRSA [5, 6] often due to secondary
complications including pressure sores and urinary tract
infections [7–9]. National Institute for Health and Care
Excellence (NICE) guidelines stipulate that infection-
control procedures in primary care are necessary to con-
trol spread and minimise MRSA impact [10, 11], but these
can vary according to local guidance. Standard practice in
the UK is to isolate patients in a single side room until they
have three consecutive negative screens (see Box 1.1 for
further MRSA infection-control guidelines as sourced via
NICE [11] and the National Health Service (NHS) England
[12]). Such measures effectively contain MRSA but can
have potentially detrimental effects on patients’ health
outcomes [13], psychological wellbeing [14, 15] and social
functioning [16, 17].
Patients who experience infection-isolation report
feeling “more vulnerable” due to negative reactions from
staff, family and other patients [18p101] in addition to
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feeling prevented from maintaining interpersonal rela-
tionships [18, 19]. Clinical care can be affected as isola-
tion is associated with infrequent visits from healthcare
staff [20, 21] and increased occurrence of preventable
adverse events [22–24]. In addition, contact precautions
impede patients’ autonomy [25] that may have critical
implications for SCI rehabilitation, as a person-centred
approach is essential for rehabilitation [26]. Outcomes of
isolation include high anger and frustration [14, 27, 28]
anxiety and depression [29–31] and reduced quality of life
[32]. Research demonstrates that infection-isolation
results in longer length of overall inpatient stay [33, 34]
and rehabilitation can be further limited by pragmatic
factors, such as restricted access to group-based psy-
choeducation, a crucial component impacting rehabilita-
tion [35, 36]. Thus, strict contact precautions imposed on
patients with MRSA can have potentially detrimental
physical and psychosocial impacts on health and rehabi-
litation, compounded by severe stigmatisation and
reduced patient autonomy [28, 37].
Despite evidence to suggest MRSA is a widespread
complication in SCI rehabilitation currently, little research
evaluates the explicit impact of such circumstances.
Instead, the literature posits a broad focus on general
hospital-acquired infections, including but not exclusively
specifying MRSA [14, 27, 38, 39]. Given the significant
societal stigmatisation of MRSA in the UK [1–4], there is a
need to represent this demographic. The prevalence of
MRSA in SCI rehabilitation is high, and the confounding
implications of infection isolation and associated stigma-
tisation may predispose patients to poorer psychological
outcomes. Thus, the purpose of this investigation is to
determine whether MRSA-related isolation experienced by
patients with SCI impacts psychological outcomes of
rehabilitation. It is hypothesised that patients who were
isolated due to positive MRSA screen(s) during inpatient
rehabilitation will demonstrate poorer psychological health




This study utilised a retrospective quantitative design
wherein secondary data were analysed to determine the
psychological outcomes of MRSA-isolated inpatients with
SCI compared with matched controls who were not isolated
without MRSA. A matched-pairs design was implemented
to account for varying functionality level of SCI in accor-
dance with previous protocol outlined by Kennedy and
Hamilton [28].
Participants
The sample included 16 participants: eight inpatients who
were isolated in a single side room due to present MRSA
and eight matched controls in six to eight bedded bays
without MRSA (see Table 1 for participant demographics).
All participants were adults aged 18+, admitted to a single
SCI rehabilitation centre in the UK between 1 February
2015 and 31 May 2018. Matched-pairs design was based on
previous SCI research methodology, in order to minimise
high levels of medical and demographic variability between
patients, which can impede between-groups comparability
[28]. Patients were matched on the following character-
istics: gender (exact match), level and grade of SCI as
determined by standardised American Spinal Injuries
Association Impairment Scale (AIS) [40] (±1 level), age at
time of injury (±5 years) and year of admission (exact
match).
Inclusion criteria for MRSA patients
Acute SCI at the time of admission, presence of MRSA
(either upon admission or developed during rehabilitation)
resulting in an infection-isolation period between February
2015 and May 2018 and a Stoke Mandeville Spinal Needs
Assessment Checklist (SMS-NAC) evaluation [41] com-
pleted within 2 weeks of admission and repeated at
discharge.
Inclusion criteria for control patients
Acute SCI on admission, no recorded stay in infection
isolation, an SMS-NAC evaluation completed within
2 weeks of admission and repeated at discharge.
Excluded participants
Participants with MRSA were excluded for the following
reasons: suitable match unavailable due to injury demo-
graphics (n= 1), isolation/infection details unavailable on
hospital record (n= 9), isolated for MRSA in a multi-
bedded bay (n= 2) and SMS-NAC not completed at dis-
charge (n= 15).
Materials and measures
The psychological health measures (anxiety, depression,
appraisals of disability, perceived manageability) and pain
intensity sections of the SMS-NAC [41] were used. The
SMS-NAC is a patient-led, internationally recognised [42]
and validated [43] comprehensive SCI outcome measure,
administered at admission and discharge to assess verbal
and physical skill acquisition and SCI knowledge [41].
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Hospital anxiety and depression scale (HADS)
The HADS [44] is regularly and reliably used in acute care
[45]. The measure comprises of two subscales to measure
anxiety and depression. The HADS has been highly cred-
ited with a mean Cronbach’s alpha value of 0.82 to 0.83
[46] to indicate high internal validity [47].
Appraisals of disability primary and secondary scale-
short form (ADAPSS-SF)
The ADAPSS-SF [48] is a self-evaluative measure of SCI
impact and disability that is used to determine how
patients perceive their own coping resources, the per-
ceived adequacy of such resources and the likelihood that
these can be employed effectively [49–51]. The measure
comprises six items and has a 6-point Likert scale to
measure how participants perceive their sense of dis-
ability in the context of their SCI. The measure is part of
the UK NHS England SCI national dashboard for
psychological outcomes with a Cronbach’s alpha value of
0.83 [48].
Perceived manageability
The perceived manageability scale (PMnac) [52, 53] was
developed to measure the extent to which patients feel they
can personally manage their SCI, both physically and
emotionally. The PMnac is based on the theory of planned
behaviour, a psychological model that postulates behaviour
is shaped by the interaction between attitudes, subjective
norms and perceived sense of control [54]. The scale
comprises of five items measured via a 4-point Likert scale.
The PMnac is used in SCI quality of life research
[53, 55, 56] and has a Cronbach’s alpha coefficient of 0.70.
Pain intensity
Pain intensity ratings were recorded using a 0–10 numerical
rating scale with 0 indicated ‘no pain’ and 10 indicating
Table 1 Participant demographics.
Participant characteristics MRSA-isolated group Non-isolated matched controls Total sample (N= 16) Median, rangea
Male, n (%) 8 (50) 8 (50) 16 (100)
Age at injury, mean (SD) 60.1 (8.9) 60.6 (6.9) 60.4 (7.7) 60.5, 45.5–71.6
Time since injury (days), mean (SD) 75.1 (25.3) 67.6 (16.9) 71.4 (21.1) 66, 39–106
Duration of stay (days), mean (SD) 181.4 (57.3) 153.9 (58.2) 167.6 (57.6) 176.5, 62–281
Ethnicity, n (%)
White British 7 (43.8) 4 (25) 11 (68.8)
Mixed: White and Black African 0 1 (6.3) 1 (6.3)
Asian or Asian British 0 1 (6.3) 1 (6.3)
Not stated 1 (6.3) 2 (12.5) 3 (18.8)
SCI level, n (%)
Thoracic 4 (25) 4 (25) 8 (50)
Cervical 3 (18.8) 3 (18.8) 6 (37.5)
Lumbar 1 (6.3) 1 (6.3) 2 (12.5)
Mechanisms of SCI, n (%)
Road traffic accident (RTA) 1 (6.3) 2 (12.5) 3 (18.8)
Falls
Domestic 2 (12.5) 1 (6.3) 3 (18.8)
Self-harm (non-suicidal) 1 (6.3) 0 1 (6.3)
Non-traumatic injury 4 (25) 4 (25) 8 (50)
Other 0 1 (6.3) 1 (6.3)
Injury level and AIS rating, n (%)
C1–4 with AIS A, B or C 1 (6.3) 1 (6.3) 2 (12.5)
C5–8 with AIS A, B or C 1 (6.3) 1 (6.3) 2 (12.5)
T1–S5 with AIS A, B or C 4 (25) 4 (25) 8 (50)
Any level with AIS D 2 (12.5) 2 (12.5) 4 (25)
n.b. % are given to 1 decimal place and indicate % of whole sample (N= 16).
aMedian and range of whole sample (N= 16).
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‘pain as bad as you can imagine’ based on the last 24 h. The
measure is the most frequently used, validated brief
assessments of pain in clinical research [57–59].
Procedure
Patients completed the SMS-NAC with a healthcare pro-
fessional. SMS-NACs are administered within 2 weeks of
admission and within 6 weeks prior to discharge. The SMS-
NAC is part of standardised treatment, with consent
obtained from patients prior to completion. The research
team conducted retrospective analyses on pre-existing
SMS-NAC data and certify that all applicable institutional
and governmental regulations were followed.
Statistics and analyses
Participants’ total length of stay is indicated by the number
of days elapsed between the date of admission and dis-
charge SMS-NAC evaluation. Statistics were completed
using R [60] with the package nparLD, which enables
nonparametric longitudinal analyses [61, 62]. The between-
groups variable (patient group; MRSA-isolated vs non-
isolated matched controls) and the within-groups variable
(time; admission and discharge) were analysed to determine
main and interaction effects on the outcome variables listed
above. Relative treatment effect (RTE) was used as a
measure of effect with the following interpretations: an RTE
value lies between 0 and 1, an RTE of 0.5 means no effect
(a randomly selected participant from the whole sample has
a 50/50 chance of achieving a lower score on an outcome
measure than a randomly selected participant from either
subgroup). An RTE < 0.5 indicates a tendency for partici-
pants in a subgroup to score lower than a random participant
from the whole sample, whereas an RTE > 0.5 is indicative
of a tendency for a participant to score higher than a ran-
domly drawn subject from the whole group. The study
utilises a nonparametric longitudinal design model, medians
and interquartile ranges for the outcome variables are pre-
sented in Table 2 [63].
Results
Participants’ demographics are presented in Table 1. There
was no significant difference in overall length of inpatient stay
between groups (MRSA-isolated vs non-isolated matched
controls), t(14)= 0.96, p= 0.36, 95% CI [−34.4, 89.4].
Anxiety and depression (HADS)
The ANOVA-type test for anxiety revealed no significant
main effect of group (F(1,∞)= 0.31, p= 0.57; RTE= 0.46
for the MRSA-isolated group, 0.54 for the non-isolated
group) or time (F(1,∞)= 0.25, p= 0.61; RTE= 0.49 for
admission, 0.51 for discharge). The interaction was also
non-significant: F(1,∞)= 2.65, p= 0.1; RTE= 0.41, 0.51 for
the MRSA-isolated group at admission and discharge,
respectively; RTE= 0.57, 0.51 for the non-isolated group at
admission and discharge, respectively, suggesting that
anxiety was not affected by isolation status.
There were no significant effects for depression, for
group (F(1,∞)= 1.5, p= 0.22; RTE= 0.42 for MRSA-
isolated group, 0.58 for the non-isolated group), or for
time (F(1,∞)= 0.01, p= 0.9; RTE= 0.49 and 0.5 for
admission and discharge, respectively). The interaction was
non-significant (F(1,∞)= 0.81, p= 0.37; RTE= 0.44, 0.40
for the MRSA-isolated group at admission and discharge,
respectively; RTE= 0.55, 0.61 for the non-isolated group at
admission and discharge, respectively) indicating that
depression was comparable in the isolated and non-isolated
groups.
Appraisals of disability (ADAPSS-SF)
Appraisals of disability showed no main effect of group
(F(1,∞)= 0.0002, p= 0.99; RTE= 0.50, 0.50 for the MRSA-
isolated group and non-isolated group) and time (F(1,∞)=
0.81, p= 0.37; RTE= 0.47, 0.53 for admission and dis-
charge, respectively). There was no significant interaction
(F(1,∞)= 0.41, p= 0.52; RTE= 0.45, 0.55 for the MRSA-
isolated group at admission and discharge, respectively;
RTE= 0.49, 0.51 for the non-isolated group at admission
Table 2 Median and interquartile range (IQR) for all outcome
measures.
MRSA-isolated group Non-isolated group
Anxiety (HADS-A)a
Admission 4 (2.8) 4.5 (4.8)
Discharge 4 (4.8) 5.5 (5.8)
Depression (HADS-D)a
Admission 4 (1.8) 5 (6.8)
Discharge 4 (4.3) 5.5 (4.3)
Appraisals of disability (ADAPSS-SF)a
Admission 15 (16.5) 15 (19.3)
Discharge 21.5 (15.5) 16.5 (7.5)
Perceived manageability (PMnac)b
Admission 15.5 (3.5) 13.5 (5.5)
Discharge 16 (5.3) 17 (6.3)
Pain rating (0–10 NRS)a
Admission 3.5 (8) 5.5 (5)
Discharge 0 (5.8) 3 (4.8)
aHigher score is indicative of worsened outcomes.
bHigher score is indicative of improved outcomes.
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and discharge, respectively). Both groups demonstrated
comparable appraisals of their disability status.
Perceived manageability (PMnac)
For perceived manageability there was no main effect of
group (F(1,∞)= 0, p= 1; RTE= 0.5, 0.5 for the MRSA-
isolated group and non-isolated group). There was, how-
ever, a significant main effect whereby perceived manage-
ability improved over time (F(1,∞)= 5.2, p= 0.02; RTE=
0.43, 0.57 for admission and discharge, respectively). There
was no significant interaction (F(1,∞)= 1.49, p= 0.22; RTE
= 0.47, 0.53 for the MRSA-isolated group at admission and
discharge, respectively; RTE= 0.39, 0.61 for the non-
isolated group at admission and discharge, respectively);
therefore, both groups showed experienced improvements
in perceived manageability during their rehabilitation and
recovery.
Pain intensity
Overall, 75% of participants reported experiencing pain as
a result of their SCI at the time of admission, whereas
56% patients reported experiencing pain at discharge,
demonstrating 19% decrease. There was no main effect of
group (F= 0.29, p= 0.58; RTE= 0.47, 0.53 for the
MRSA-isolated group, non-isolated group, respectively)
but there was a significant main effect of time indicating
improved pain scores at discharge (F(1,∞)= 5.11; p= 0.02;
RTE= 0.58 for admission RTE= 0.42 for discharge).
There was no significant interaction (F(1,∞)= 0.33, p=
0.57; RTE= 0.53, 0.41 for the MRSA-isolated group at
admission and discharge, respectively; RTE= 0.64, 0.43
for the non-isolated group at admission and discharge,
respectively).
Discussion
Results demonstrated no conclusive general psychological
health outcome differences between patients who were
isolated for MRSA in a single side room compared with
non-isolated patients without MRSA. Perceived manage-
ability of SCI and pain intensity outcomes improved over
time in rehabilitation, irrespective of MRSA status, though
it is important to consider the small variation in RTEs.
There was no difference in the overall length of inpatient
stay between the MRSA-isolated group and non-isolated
matched controls.
It is possible that MRSA isolation had no main effect on
psychological outcomes due to variability in patients’
individual perceptions of isolation, perhaps in relation to the
quality (rather than quantity) of social interactions which
continued during isolation—a factor that was not assessed
within the current investigation. Research distinguishes
between feeling and being isolated and this is critical for
patient experience and clinical implications; it is possible to
experience being alone without simultaneously feeling
lonely [64]. Thus, an important factor in shaping patients’
isolation experiences is social capital—a protective
mechanism found to insulate the individual from biopsy-
chosocial stressors, bolstering psychological wellbeing via
social connectedness [65]. Sources for such social capital
and interaction can be ascertained via healthcare staff,
hospital porters, visitors and other patients. Indeed, nurses
have been found to offer both informational and emotional
support to patients [66], which can provide sufficient
interaction to protect against feeling lonely in isolation,
potentially minimising negative psychological impact.
Notably, the quality of such social interaction, not
necessarily the spread of social networks, impacts percep-
tions of loneliness and psychological health [67]; fewer,
high-quality interactions can be more protective and foster
enough social connectedness to buffer against anxiety,
depression and loneliness [68]. Given the literature, the non-
significant finding in the present study could therefore be
due to a skilled staff providing additional emotional sup-
port. However, this was not controlled in the present study
and needs to be evidenced further. There are potential
implications for other infection-control settings, not just
those relating to MRSA, particularly given the recent
COVID-19 pandemic and associated imposed isolation
experienced worldwide [69–71]. With this cohesive appre-
ciation for social connectedness and the potential barriers
incurred during imposed isolation [71, 72] healthcare staff,
peers and relatives’ perceptions of what it means to be
isolated may lead to reduced stigmatisation and improved
social connectedness.
The strength of therapeutic relationships should also be
considered in explaining how patients’ experiences of SCI
rehabilitation are shaped [73]. A biopsychosocial approach
to SCI rehabilitation has a strong evidence base [74, 75],
incorporating multi-domain progress via physiotherapy
[76], occupational therapy and clinical psychological ther-
apy [77], goal planning [78] and psychosocial education
[36, 75]. As a result of this integrated approach, many
individuals in the current study would have received some
form of psychological intervention as a standard part of
inpatient rehabilitation. During such therapeutic sessions
any negative psychosocial effects of MRSA isolation will
likely have been addressed (either directly or indirectly) by
appropriate clinical intervention [77, 79]. This psychologi-
cal support could have provided a robust defence against
worsened outcomes of isolation, and therefore potentially
explain why there were no differences in psychological
measures between groups.
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Pain intensity and perceived manageability improved
over time, demonstrating the positive impact of diverse and
intense rehabilitation. SCI requires extensive adjustment
[49, 55] and such adaptation requires support from multiple
disciplines to provide a cohesive, manageable care plan for
patients. Consequently, it can be inferred that a diverse,
multi-faceted rehabilitation programme can have numerous
health benefits for individuals with SCI including improved
perceptions of manageability and coping post injury as well
as in relation to pain outcomes.
The implications of MRSA isolation on overall length of
stay during inpatient rehabilitation are potentially para-
mount. In the current study, there was no difference
between the MRSA-isolated group and the non-isolated
group in overall length of inpatient stay. However, one
potential confounding variable was the amount of time
spent in isolation, which has previously been related to
longer overall hospitalisation [33, 34]. Average length of
stay for SCI patients is diverse within the literature [80]
spanning from 47 days in Russia [81] to 240 days in the
Netherlands [82], with non-traumatic injury in the UK
averaging 143 days [83]. Length of stay can implicitly
impact rehabilitation outcomes [33, 84] and lead to reduced
functional independence [85]. However, the evidence from
the current study would argue that length of stay was not
substantially longer than that of non-isolated matched
controls and no detrimental impact on psychological health
aspects was incurred by those who were isolated. This
suggests that infection-isolation control protocols such as
those outlined in Box 1.1, as employed within NHS Eng-
land, remain valid and are unlikely to impede rehabilitation
outcomes.
Limitations
This study is limited by small, specific sampling at a
single site. Although the specialist SCI centre used in this
study accepts adult patient referrals across 30% of Eng-
land, the strict inclusion and exclusion criteria utilised in
this study may limit the generalisability of findings. To
minimise potential selection bias, the current research
utilised a well-evidenced matched-pairs design [28],
controlling for wide variation in injury-related demo-
graphics. The current study assessed a specific selection of
psychological outcomes in accordance with the previous
literature [56, 86]; however, future research could further
interrogate the impact of infection isolation by assessing
in greater depth a wider variety of biopsychosocial mea-
sures. A further limitation is the lack of controlling for
variation in length of time spent in isolation relative to
overall length of inpatient stay, which would naturally
impact experiences of isolation [84]. Though this study
intentionally focused on MRSA-related isolation
specifically, the anticipated and felt social stigma of other
infections [87, 88] and societal stigma variation world-
wide [89] may differentially impact outcomes. Future
research comparing rehabilitation experiences sampled
across various sites with multiple infection-control pro-
tocols and durations would be highly beneficial to the
literature and inform clinical practice.
Conclusion
The current study provides novel findings into the psy-
chological outcomes of individuals with SCI who simulta-
neously experience MRSA-specific contact precautions.
This article provides advocacy for an integrated, multi-
dimensional approach to SCI rehabilitation to improve
outcomes in perceived manageability and pain. Outcomes
provide support for NHS England infection-control protocol
for MRSA in primary care; as contrary to much literature,
there were no detrimental effects on the psychological
wellbeing of patients with SCI. Although the patients in this
study did not experience isolation during the recent
COVID-19 pandemic, the discussed factors in relation to
the experiences of MRSA isolation may provide some
parallels in clinical practice. This research may be a useful
comparator and avenue for future study in relation to such
variables of recent interest.
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